Docebo Inc.

TSX:DCBO.TO

70.92 (CAD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 53.05451.40349.2846.50643.59441.45938.95536.96634.93632.05529.80127.06825.63121.74218.75616.09614.53513.5312.29810.5879.9238.6368.056.8926.4366.066
Cost of Revenue 10.2579.9269.2558.7798.418.0547.5077.146.9796.5526.0875.6835.1523.8642.9752.8832.8482.8332.2862.092.0681.8511.5231.4141.5081.357
Gross Profit 42.79741.47740.02537.72735.18433.40531.44829.82627.95725.50323.71421.38520.47917.87815.78113.21311.68710.69710.0128.4977.8546.7856.5265.4784.9284.71
Gross Profit Ratio 0.8070.8070.8120.8110.8070.8060.8070.8070.80.7960.7960.790.7990.8220.8410.8210.8040.7910.8140.8030.7920.7860.8110.7950.7660.776
Reseach & Development Expenses 10.76610.4129.02310.2718.8087.3776.3776.1056.116.1865.5055.4815.2344.1433.5243.2653.3032.9082.7761.9621.982.0661.981.5391.6221.546
General & Administrative Expenses 10.09910.08710.18110.16210.6718.8238.4768.8249.1278.4697.8647.5627.4637.8156.044.0873.8274.6634.8314.113.8782.673.3792.6472.4662.395
Selling & Marketing Expenses 16.89516.43316.16316.22118.04816.77215.50415.52314.8813.74712.63811.14210.4479.1196.4615.7965.8785.8854.5555.1543.3313.6913.0672.7523.0892.906
SG&A 26.99426.5226.34426.38328.71925.59523.9824.34724.00722.21620.50218.70417.9116.93412.5019.8839.70510.5489.3869.2647.2086.3616.4465.3995.5555.37
Other Expenses 0.0140.00100.00200.7070.6020.5640.5870.580.0210.0210.0220.0210.020.0190.0190.0190.0190.019-0.284-0.453-0.485-0.512-0.5190
Operating Expenses 38.58437.7535.92137.7138.35133.67930.95931.01630.70428.98226.56224.68623.63321.55116.48513.42713.26213.69412.26111.4349.3888.6148.4746.9867.2077.77
Operating Income 4.5234.2271.0793.109-7.5221.7851.0530.247-2.747-3.479-2.9461.464-6.343-5.624-4.086-0.654-3.2420.717-3.069-3.084-1.798-1.859-2.473-1.427-2.764-2.242
Operating Income Ratio 0.0850.0820.0220.067-0.1730.0430.0270.007-0.079-0.109-0.0990.054-0.247-0.259-0.218-0.041-0.2230.053-0.25-0.291-0.181-0.215-0.307-0.207-0.429-0.37
Total Other Income Expenses Net 0.3240.501-1.873.094-4.355-0.1770.72810.1225.209-3.351-0.0774.786-3.167-1.93-3.362-0.421-1.6483.733-0.801-0.128-0.549-0.483-1.01-0.431-1.004-0.947
Income Before Tax 5.2084.7733.315.044-5.1161.6081.78110.3692.462-6.83-2.8871.456-6.397-5.601-4.159-0.713-3.2650.819-3.139-3.293-2.336-2.538-3.16-2.114-3.448-3.189
Income Before Tax Ratio 0.0980.0930.0670.108-0.1170.0390.0460.2810.07-0.213-0.0970.054-0.25-0.258-0.222-0.044-0.2250.061-0.255-0.311-0.235-0.294-0.393-0.307-0.536-0.526
Income Tax Expense 0.51-0.3960.0880.9970.5580.3630.1810.0950.3590.129-1.4590.7950.7930.043-0.4180.4450.2330.0760.160.449-0.053-0.234-0.329-0.357-0.365-0.189
Net Income 4.6985.1693.2224.047-5.6741.2451.610.2742.103-6.959-1.4280.661-7.19-5.644-3.741-1.158-3.4980.743-3.299-3.742-2.336-2.538-3.16-2.114-3.448-3
Net Income Ratio 0.0890.1010.0650.087-0.130.030.0410.2780.06-0.217-0.0480.024-0.281-0.26-0.199-0.072-0.2410.055-0.268-0.353-0.235-0.294-0.393-0.307-0.536-0.494
EPS 0.210.170.10.12-0.170.040.050.310.064-0.21-0.0430.02-0.22-0.17-0.11-0.04-0.120.03-0.12-0.13-0.082-0.089-0.11-0.074-0.12-0.15
EPS Diluted 0.210.170.10.12-0.170.040.050.30.062-0.21-0.0430.02-0.22-0.17-0.11-0.04-0.120.03-0.11-0.13-0.082-0.084-0.11-0.07-0.11-0.15
EBITDA 5.775.1425.8033.0870.1362.4921.6550.811-1.697-2.768-2.195-2.706-2.539-3.061-0.1550.11-1.268-2.565-2.136-2.71-1.64-2.102-2.431-1.992-2.779-2.206
EBITDA Ratio 0.1090.10.1180.0660.0030.060.0420.022-0.049-0.086-0.074-0.1-0.099-0.141-0.0080.007-0.087-0.19-0.174-0.256-0.165-0.243-0.302-0.289-0.432-0.364